A high quality scientific journal with an international readershipOfficial publication of the SFD, Diabetes & Metabolism, publishes high-quality papers by leading teams, forming a close link between hospital and research units. Diabetes & Metabolism is published in English language and is indexed in all major databases with its impact factor constantly progressing.Diabetes & Metabolism contains original articles, short reports and comprehensive reviews. The latter are updates written by internationally recognized specialists carefully edited in order to help clinicians and researchers keep informed about the latest developments in the field of diabetes.
拥有国际读者的高质量科学期刊SFD的官方出版物《糖尿病与代谢》发表了领先团队的高质量论文，在医院和研究单位之间形成了密切的联系。Diabetes & Metabolism以英语出版，并在所有主要数据库中被索引，其影响因素不断进步。Diabetes & Metabolism包含原创文章，简短报告和综合评论。后者是由国际公认的专家精心编辑的更新，以帮助临床医生和研究人员了解糖尿病领域的最新发展。
Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complications.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.01.008
Burden of diabetes, hyperglycaemia in China from to 2016: Findings from the 1990 to 2016, global burden of disease study.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.08.008
Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10).
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.101117
Effects of glucose-lowering agents on surrogate endpoints and hard clinical renal outcomes in patients with type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.10.003
Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.05.010
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1-7 trials.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.12.001
Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.02.006
Complement activation in patients with diabetic nephropathy.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.04.001
Serum soluble TREM2 is a potential novel biomarker of cognitive impairment in Japanese non-obese patients with diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2017.06.006
Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.01.006
Metabolomics signatures associated with an oral glucose challenge in pregnant women.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.01.004
Links between aldosterone excess and metabolic complications: A comprehensive review.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.02.003
Association of C-peptide with diabetic vascular complications in type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.04.004
Performance of a selective screening strategy for diagnosis of hyperglycaemia in pregnancy as defined by IADPSG/WHO criteria.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.09.002
Obesity paradox in associations between body mass index and diabetes-related hospitalization and mortality in patients with type 2 diabetes: Retrospective cohort studies.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.02.007
Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.02.002
Clinical characteristics of diabetic ketoacidosis in users and non-users of SGLT2 inhibitors.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.01.001
Obstructive sleep apnoea syndrome in patients living with diabetes: Which patients should be screened?
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.08.006
Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.11.004
A systematic literature review of observational studies of the bidirectional association between metabolic syndrome and migraine.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2017.12.004
Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2017.06.007
Limited benefit of haemoglobin glycation index as risk factor for cardiovascular disease in type 2 diabetes patients.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.04.006
Association between BMI and risk of severe hypoglycaemia in type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.03.006
The gut microbiota and diabetic cardiomyopathy in humans.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.10.003
Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.05.008
The prognostic significance of glutamic acid decarboxylase antibodies in patients with chronic pancreatitis undergoing total pancreatectomy with islet autotransplantation.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.01.001
Evacuation is a risk factor for diabetes development among evacuees of the Great East Japan earthquake: A 4-year follow-up of the Fukushima Health Management Survey.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2017.09.005
Effect of liraglutide on physical performance in type 2 diabetes: Results of a randomized, double-blind, controlled trial (LIPER2).
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.08.010
Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.10.004
Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.11.003
Metformin is associated with a lower risk of non-Hodgkin lymphoma in patients with type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.05.002
Associations of serum magnesium levels and calcium-magnesium ratios with mortality in patients with coronary artery disease.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.12.003
High expression of CPT1b in skeletal muscle in metabolically healthy older subjects.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.01.018
Insulin resistance and NAFLD: Relationship with intrahepatic iron and serum TNF-α using 1H MR spectroscopy and MRI.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.01.005
Diabetes-related distress is reduced in people with type 1, but not type 2 diabetes after participating in a diabetes treatment and teaching programme.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2017.11.008
Effect of short-term intensive insulin therapy on the incretin response in early type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.01.003
Dietary sodium and potassium and risk of diabetes: A prospective study using data from the China Health and Nutrition Survey.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.12.002
Circulating omega-7 fatty acids are differentially related to metabolic dysfunction and incident type II diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA).
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.10.005
Alirocumab efficacy and safety by body mass index: a pooled analysis from 10 Phase 3 ODYSSEY trials.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.101120
Serum fructosamine predicts macrosomia in well-controlled hyperglycaemic pregnant women: an observational cross-sectional study.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.07.003
Disagreement between capillary blood glucose and flash glucose monitoring sensor can lead to inadequate treatment adjustments during pregnancy.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.08.001
Insulin secretion in response to high extracellular calcium is not a pathognomonic feature of insulinoma cells.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2017.07.008
Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.11.005
Metabolic And Psychological Effects Of Short-Term Increased Consumption Of Less-Processed Foods In Daily Diets: A Pilot Study.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.07.002
SGLT2 Inhibition Increases Serum Copeptin in Young Adults with Type 1 Diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.11.006
Current status of insulin degludec in type 1 and type 2 diabetes based on randomized and observational trials.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.04.007
Low normal fasting glucose and risk of accidental death in Korean adults: A prospective cohort study.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.01.005
The association between handgrip strength and sleep duration in Japanese patients with type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2017.07.005
Heart rate variability in fetuses of type 1 diabetes pregnancies.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2017.07.002
Competing risk analysis on visit-to-visit glucose variations and risk of depression: The Taiwan Diabetes Study.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.08.003
